{{Rsnum
|rsid=1887427
|Chromosome=9
|position=4979730
|Orientation=plus
|GMAF=0.1997
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=132
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 64.6 | 29.2 | 6.2
| HCB | 67.6 | 32.4 | 0.0
| JPT | 63.7 | 34.5 | 1.8
| YRI | 83.7 | 15.6 | 0.7
| ASW | 77.2 | 21.1 | 1.8
| CHB | 67.6 | 32.4 | 0.0
| CHD | 72.5 | 24.8 | 2.8
| GIH | 69.3 | 28.7 | 2.0
| LWK | 80.7 | 17.4 | 1.8
| MEX | 60.3 | 32.8 | 6.9
| MKK | 66.2 | 30.5 | 3.2
| TSI | 50.0 | 46.1 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=21292633
|Title=Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients
|OA=1
}}

{{PMID|19604093|OA=1
}} Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients.

{{PMID Auto
|PMID=23717640
|Title=Janus Kinase 2 Polymorphisms Are Associated with Risk in Patients with Gastric Cancer in a Chinese Population
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}